東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/25 | 2,070 | 2,070 | 2,040 | 2,044 | -20 | -1% | 54,500 |
2023/01/24 | 2,061 | 2,075 | 2,055 | 2,064 | +20 | +1% | 46,000 |
2023/01/23 | 2,045 | 2,059 | 2,040 | 2,044 | +6 | +0.3% | 45,100 |
2023/01/20 | 2,023 | 2,040 | 2,020 | 2,038 | +12 | +0.6% | 31,400 |
2023/01/19 | 2,035 | 2,035 | 2,017 | 2,026 | -15 | -0.7% | 35,900 |
2023/01/18 | 2,008 | 2,042 | 2,008 | 2,041 | +36 | +1.8% | 55,700 |
2023/01/17 | 2,001 | 2,017 | 1,999 | 2,005 | -2 | -0.1% | 58,900 |
2023/01/16 | 2,001 | 2,023 | 1,999 | 2,007 | -6 | -0.3% | 49,600 |
2023/01/13 | 2,008 | 2,024 | 1,983 | 2,013 | +3 | +0.1% | 137,100 |
2023/01/12 | 2,012 | 2,022 | 2,008 | 2,010 | -4 | -0.2% | 54,300 |
2023/01/11 | 2,027 | 2,034 | 2,012 | 2,014 | ±0 | ±0% | 84,100 |
2023/01/10 | 2,039 | 2,040 | 2,003 | 2,014 | -7 | -0.3% | 98,200 |
2023/01/06 | 2,043 | 2,049 | 2,021 | 2,021 | -22 | -1.1% | 76,300 |
2023/01/05 | 2,066 | 2,071 | 2,043 | 2,043 | -25 | -1.2% | 58,700 |
2023/01/04 | 2,130 | 2,130 | 2,067 | 2,068 | -63 | -3% | 57,700 |
2022/12/30 | 2,144 | 2,156 | 2,131 | 2,131 | -4 | -0.2% | 43,900 |
2022/12/29 | 2,127 | 2,143 | 2,115 | 2,135 | +3 | +0.1% | 60,400 |
2022/12/28 | 2,123 | 2,132 | 2,109 | 2,132 | +7 | +0.3% | 46,400 |
2022/12/27 | 2,101 | 2,125 | 2,101 | 2,125 | +22 | +1% | 58,800 |
2022/12/26 | 2,129 | 2,129 | 2,099 | 2,103 | -26 | -1.2% | 45,200 |
2022/12/23 | 2,110 | 2,129 | 2,102 | 2,129 | +25 | +1.2% | 68,100 |
2022/12/22 | 2,090 | 2,108 | 2,071 | 2,104 | +21 | +1% | 60,400 |
2022/12/21 | 2,097 | 2,097 | 2,072 | 2,083 | -12 | -0.6% | 89,900 |
2022/12/20 | 2,110 | 2,133 | 2,078 | 2,095 | -15 | -0.7% | 102,300 |
2022/12/19 | 2,130 | 2,130 | 2,105 | 2,110 | -34 | -1.6% | 55,100 |
2022/12/16 | 2,143 | 2,161 | 2,137 | 2,144 | -23 | -1.1% | 78,000 |
2022/12/15 | 2,148 | 2,169 | 2,146 | 2,167 | +25 | +1.2% | 70,100 |
2022/12/14 | 2,140 | 2,150 | 2,133 | 2,142 | +11 | +0.5% | 42,400 |
2022/12/13 | 2,121 | 2,138 | 2,121 | 2,131 | +12 | +0.6% | 68,100 |
2022/12/12 | 2,080 | 2,129 | 2,074 | 2,119 | +45 | +2.2% | 97,400 |
2022/12/09 | 2,025 | 2,077 | 2,025 | 2,074 | +26 | +1.3% | 66,800 |
2022/12/08 | 2,050 | 2,052 | 2,030 | 2,048 | +4 | +0.2% | 55,700 |
2022/12/07 | 2,020 | 2,049 | 2,017 | 2,044 | +15 | +0.7% | 64,000 |
2022/12/06 | 2,035 | 2,057 | 2,029 | 2,029 | -13 | -0.6% | 64,600 |
2022/12/05 | 2,078 | 2,080 | 2,035 | 2,042 | -22 | -1.1% | 109,400 |
2022/12/02 | 2,095 | 2,095 | 2,054 | 2,064 | -37 | -1.8% | 84,400 |
2022/12/01 | 2,118 | 2,121 | 2,091 | 2,101 | -11 | -0.5% | 76,500 |
2022/11/30 | 2,106 | 2,127 | 2,101 | 2,112 | -10 | -0.5% | 82,100 |
2022/11/29 | 2,093 | 2,129 | 2,084 | 2,122 | +9 | +0.4% | 61,400 |
2022/11/28 | 2,135 | 2,136 | 2,105 | 2,113 | -22 | -1% | 45,100 |
2022/11/25 | 2,144 | 2,147 | 2,120 | 2,135 | +4 | +0.2% | 51,400 |
2022/11/24 | 2,106 | 2,131 | 2,102 | 2,131 | +44 | +2.1% | 81,600 |
2022/11/22 | 2,104 | 2,110 | 2,079 | 2,087 | -7 | -0.3% | 84,300 |
2022/11/21 | 2,117 | 2,126 | 2,094 | 2,094 | -13 | -0.6% | 84,900 |
2022/11/18 | 2,079 | 2,116 | 2,076 | 2,107 | +40 | +1.9% | 101,700 |
2022/11/17 | 2,050 | 2,071 | 2,043 | 2,067 | +17 | +0.8% | 118,400 |
2022/11/16 | 2,068 | 2,074 | 2,014 | 2,050 | -40 | -1.9% | 234,900 |
2022/11/15 | 2,158 | 2,187 | 2,089 | 2,090 | -106 | -4.8% | 298,200 |
2022/11/14 | 2,187 | 2,207 | 2,178 | 2,196 | -25 | -1.1% | 84,700 |
2022/11/11 | 2,225 | 2,232 | 2,214 | 2,221 | +30 | +1.4% | 76,900 |
451~
500
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム